KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseExpense - Property Taxes and InsuranceExpense - Property and MaintenanceLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherRevenue - Mortgage Backed SecuritiesRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

National Health Investors (NHI) Shares Outstanding (2016 - 2026)

National Health Investors filings provide 18 years of Shares Outstanding readings, the most recent being $48.3 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 3.45% to $48.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $48.3 million, a 3.45% increase, with the full-year FY2025 number at $48.3 million, up 5.72% from a year prior.
  • Shares Outstanding hit $48.3 million in Q1 2026 for National Health Investors, roughly flat from $48.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $48.3 million in Q4 2025 to a low of $43.4 million in Q3 2022.
  • Median Shares Outstanding over the past 5 years was $43.6 million (2024), compared with a mean of $44.9 million.
  • Biggest five-year swings in Shares Outstanding: fell 5.37% in 2023 and later grew 9.28% in 2025.
  • National Health Investors' Shares Outstanding stood at $43.4 million in 2022, then increased by 0.05% to $43.4 million in 2023, then increased by 5.25% to $45.7 million in 2024, then grew by 5.72% to $48.3 million in 2025, then changed by 0.0% to $48.3 million in 2026.
  • The last three reported values for Shares Outstanding were $48.3 million (Q1 2026), $48.3 million (Q4 2025), and $45.7 million (Q3 2025) per Business Quant data.